Search Results

Synaptive Medical Welcomes Chris Marrus as New Chief Commercial Officer

Synaptive Medical Inc., a global med tech and technology company solving surgical, imaging and data challenges, is proud to announce the appointment of Chris Marrus as Chief Commercial Officer.

February 29, 2024

·

3 min read

Synaptive Medical Showcases First Clinical Use of Near-Infrared Fluorescence Visualization on Robotic Exoscope at the American Association of Neurological Surgeons Annual Meeting

Synaptive Medical Inc., a global med tech and technology company solving surgical, imaging and data challenges, will showcase its near-infrared fluorescence visualization setting, Modus IR, at this year’s American Association of Neurological Surgeons (AANS) meeting, taking place in Chicago, Illinois, from May 3 – 6.

April 30, 2024

·

2 min read

Synaptive Medical Receives FDA 510(k) Clearance for Near-Infrared Fluorescence Visualization, Expanding Application of Existing Robotic Exoscope

Synaptive Medical Inc. has received 510(k) clearance from the Food and Drug Administration (FDA) for its Near-Infrared fluorescence visualization module, Modus IR, adding to the existing fluorescence offering on its 4K 3D robotic exoscope, Modus X.

March 27, 2024

·

2 min read

Press Releases

Gate Neurosciences Presents New Data and Insights Highlighting Unique Pharmacology of Synaptic Function Modulators at the 2024 ACNP Annual Meeting

December 12, 2024

·

5 min read

Synaptive Medical Welcomes Provincial Investment to Expand Manufacturing and R&D Activities

Synaptive Medical has received $900,000 in support from the Ontario government through the Ontario Together Fund.

August 2, 2023

·

2 min read

Business

Synaptive Medical Announces Timothy J. Scannell as New Chair of Board of Directors

Synaptive Medical, a global medical device and technology company solving surgical, imaging and data challenges, is pleased to announce the appointment of Timothy J. Scannell as the new Chair of the Board of Directors, effective June 20, 2023.

August 10, 2023

·

2 min read

Synaptive Announces U.S. and Canadian Availability of Next-Generation Robotic-Exoscope, Modus X

Synaptive Medical Inc., a global medical technology innovator, announced FDA registration for the next-generation of its robotic exoscope.

March 22, 2023

·

2 min read

Synaptive Medical Partners with Panaxium to Bring Real-Time Intelligent High-Resolution Cortical Mapping to Neurosurgical OR

Synaptive Medical Inc. announced a joint-development partnership with bioelectronic medicine company Panaxium SAS to incorporate Panaxium’s ultra-flexible iontronic electrocorticography platform into Synaptive’s Modus V robotic exoscope technology.

October 11, 2022

·

4 min read

Drug Development

QurAlis to Present Data That Show TDP-43 Pathology Drives Loss of Synaptic UNC13A Function in Neurodegenerative Diseases Including ALS and Frontotemporal Dementia

QurAlis Corporation today announced it will present preclinical data showing that TDP-43 (TAR DNA-binding protein 43) pathology drives loss of synaptic UNC13A function in neurodegenerative diseases including ALS and FTD.

November 29, 2023

·

3 min read

Synaptive Medical Inc., Launches Dynamic Free Water Correction Feature to Enhance Planning and Navigation Technology

Synaptive Medical Inc., a leader in automated brain mapping and enriched patient data, announced the launch of Reveal , a powerful new feature for its Modus™ Plan software.

October 6, 2022

·

3 min read